TLDR Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.
The study at an Italian tertiary care center followed 100 COVID-19 patients 60 days after hospital discharge, revealing that 84% experienced persistent symptoms, such as fatigue, dyspnea, and insomnia, with fatigue being the most common at 46%. Unusual symptoms like hair loss were reported by 8% of patients, with a noted link to male pattern baldness. The persistence of symptoms was not related to the initial severity of COVID-19, ICU admission, or hospital stay length, but older age increased the risk of symptom persistence. Additionally, 10% of patients were readmitted, often due to cardiac issues, and 19% experienced rectal colonization with multidrug-resistant bacteria. The study emphasized the importance of continued monitoring and care for recovering COVID-19 patients to address ongoing health issues and improve their quality of life.
134 citations
,
April 2020 in “Journal of Cosmetic Dermatology” Male pattern hair loss could hint at androgens affecting COVID-19 severity.
2 citations
,
January 1980 in “Acupuncture & electro-therapeutics research” Hair loss might be due to nerve issues, treatable with electric stimulation or acupuncture.
26 citations
,
October 2012 in “Dermatologic Clinics” The document details hair transplantation techniques and innovations, highlighting Follicular Unit Transplantation as the standard and discussing the effectiveness and challenges of the procedure.
5 citations
,
January 2012 in “Dermatology” Adapted classification better assesses male pattern hair loss and its link to heart disease.
January 2024 in “Journal of Cosmetics, Dermatological Sciences and Applications” Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.
32 citations
,
January 2018 in “American Journal of Clinical Dermatology” Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.
17 citations
,
January 2016 in “American Journal of Epidemiology” Men with male pattern baldness have a higher risk of dying from prostate cancer.